| Autor: |
Shapiro MD; Center for Prevention of Cardiovascular Disease, Section on Cardiovascular Medicine, Wake Forest University School of Medicine, Winston Salem, NC, USA. |
| Jazyk: |
angličtina |
| Zdroj: |
American journal of preventive cardiology [Am J Prev Cardiol] 2024 Aug 19; Vol. 19, pp. 100717. Date of Electronic Publication: 2024 Aug 19 (Print Publication: 2024). |
| DOI: |
10.1016/j.ajpc.2024.100717 |
| Abstrakt: |
Competing Interests: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Michael D. Shapiro reports a relationship with Amgen Inc that includes: consulting or advisory. Michael D. Shapiro reports a relationship with Ionis Pharmaceuticals Inc that includes: consulting or advisory. Michael D. Shapiro reports a relationship with Tourmaline Bio, Inc. that includes: consulting or advisory. Michael D. Shapiro reports a relationship with Regeneron Pharmaceuticals Inc that includes: consulting or advisory. Michael D. Shapiro reports a relationship with Novo Nordisk Inc that includes: consulting or advisory. Michael D. Shapiro reports a relationship with Merck & Co Inc that includes: consulting or advisory. Michael D. Shapiro reports a relationship with Arrowhead Pharmaceuticals Inc that includes: consulting or advisory. Michael D. Shapiro reports a relationship with Kaneka Corporation that includes: consulting or advisory. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
